David M. Livingston, MD (Damon Runyon Board Member), of Dana-Farber Cancer Institute, Boston, has been named the 20th recipient of the Pezcoller Foundation-AACR International Award for Cancer Research. Dr. Livingston is honored for his fundamental contributions to the field of basic cancer research. His work has been pivotal to the understanding of retinoblastoma pathway of cell cycle control as well as the transcriptional co-activation function of the key regulatory proteins, p300 and CBP. He is also credited with the landmark discovery of the central functions of the tumor suppressors, BRCA1 and BRCA2, which has revolutionized the fields of breast and ovarian cancer research. He will deliver his award lecture at the AACR Annual Meeting this April in Washington, DC.
